[Complement-mediated hemolytic uremic syndrome: a diagnostic approach]

Area of Science:

• Nephrology
• Hematology
• Immunology

Background:

• Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy.
• It presents with hemolytic anemia, thrombocytopenia, and renal impairment.
• aHUS results from alternative complement pathway dysregulation on endothelial cells, leading to microvascular thrombosis.

Purpose of the Study:

• To outline the diagnostic approach for atypical hemolytic uremic syndrome (aHUS).
• To differentiate aHUS from other hemolytic syndromes and thrombotic microangiopathies.

Main Methods:

• Review of diagnostic criteria for aHUS.
• Comparison with differential diagnoses including STEC-HUS, TTP, and vitamin B12 metabolism errors.

Main Results:

• aHUS diagnosis requires identifying complement dysregulation.
• Differential diagnosis is key due to overlapping symptoms with other conditions.

Conclusions:

• Accurate diagnosis of aHUS is essential for appropriate management.
• Understanding the underlying complement pathway dysregulation aids in distinguishing aHUS.